过去一年中添加的文章,按日期排序
[PDF][PDF] Progressive pulmonary fibrosis: a need for real world data to solve real world clinical problems
H Liu, KM Heenan, L Coyle, N Chaudhuri - BMJ medicine, 2024 - pure.ulster.ac.uk
35 天前 - … Idiopathic pulmonary fibrosis (IPF) is the archetypal progressive fibrotic lung disease
for which there is currently no cure… pathogenesis between progressive pulmonary fibrosis …
for which there is currently no cure… pathogenesis between progressive pulmonary fibrosis …
A bibliometric analysis of cystic fibrosis transmembrane conductance regulators
59 天前 - … The primary mechanism is an abnormality in the transfer of sodium and chloride
across secretory epithelia caused by pathogenic mutations of the cystic fibrosis transmembrane …
across secretory epithelia caused by pathogenic mutations of the cystic fibrosis transmembrane …
Regulation of myofibroblast dedifferentiation in pulmonary fibrosis
X Ju, K Wang, C Wang, C Zeng, Y Wang, J Yu - Respiratory Research, 2024 - Springer
65 天前 - … in the pathophysiology of pulmonary fibrosis, significantly … could provide new
directions for therapeutic development. … studies on treatment for idiopathic pulmonary fibrosis (IPF…
directions for therapeutic development. … studies on treatment for idiopathic pulmonary fibrosis (IPF…
[HTML][HTML] A Global Effort to Stop the Vicious Vortex: A Special American Journal of Respiratory and Critical Care Medicine Issue for World Bronchiectasis Day 2024
M Shteinberg, G Waterer… - American Journal of …, 2024 - ncbi.nlm.nih.gov
87 天前 - … of bronchiectasis pathogenesis includes several aspects of disease pathophysiology.
… stasis, chronic airway infection with pathogenic bacteria, chronic airway inflammation, …
… stasis, chronic airway infection with pathogenic bacteria, chronic airway inflammation, …
[HTML][HTML] Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives
E Sciacca, G Muscato, L Spicuzza… - Multidisciplinary …, 2024 - ncbi.nlm.nih.gov
100 天前 - … therapies, ongoing clinical trials, and future directions in the search for more effective
treatments… to deepen our understanding of the pathogenetic mechanisms underlying IPF, …
treatments… to deepen our understanding of the pathogenetic mechanisms underlying IPF, …
Molecular Mechanisms and Roles of MiR-136-5p in Human Cancer and Other Disorders
X Chen, T Lu, Y Zheng, Z Lin, C Liu… - Current Medicinal …, 2024 - ingentaconnect.com
148 天前 - … sclerosis, idiopathic pulmonary fibrosis, and polycystic ovary … to promote drug
resistance to a variety of medications. … pathogenic roles of miRNAs in human diseases is crucial. …
resistance to a variety of medications. … pathogenic roles of miRNAs in human diseases is crucial. …
Pancreatic Cancer
S Pant - Springer
166 天前 - … in the pathogenesis of diseases… future directions to improve outcomes in this
devastating disease. This book will provide a comprehensive, global overview on current therapies …
devastating disease. This book will provide a comprehensive, global overview on current therapies …
Productive cough associated with patient-reported outcomes and computed tomography analysis results in idiopathic pulmonary fibrosis: a single centre cross …
K Fujita, Y Kanemitsu, H Ohkubo, A Okada… - … Open Research, 2024 - Eur Respiratory Soc
265 天前 - Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic pulmonary disease that
causes … However, the effect of cough on the pathophysiology of IPF has not been extensively …
causes … However, the effect of cough on the pathophysiology of IPF has not been extensively …
[HTML][HTML] Advances in cystic fibrosis-related diabetes: Current status and future directions
F Lurquin, M Buysschaert, V Preumont - … Syndrome: Clinical Research & …, 2023 - Elsevier
324 天前 - … The aim of this review is to give an update of the recent advances in the
pathophysiology, prognosis, diagnosis and treatments of cystic fibrosis-related diabetes (CFRD). …
pathophysiology, prognosis, diagnosis and treatments of cystic fibrosis-related diabetes (CFRD). …
Current and future treatment landscape for idiopathic pulmonary fibrosis
F Bonella, P Spagnolo, C Ryerson - Drugs, 2023 - Springer
331 天前 - … the key pathogenetic concepts for the development of new antifibrotic … therapies,
and summarizes new compounds currently in clinical development. Finally, future directions in …
and summarizes new compounds currently in clinical development. Finally, future directions in …